Phanes Therapeutics, Inc.
10Patents
10Active
10Granted
46Portfolio score
Filing activity: Jul 26, 2018 → Jun 4, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11214615B2 | Anti-TIM-3 antibodies and uses thereof | Physics | 0 | Active |
| US11555070B2 | Anti-claudin 18.2 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11390679B2 | Anti-LAG-3 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11873335B2 | Anti-folate receptor 1 antibodies and uses thereof | Physics | 0 | Active |
| US12037391B2 | Anti-DLL3 antibodies and uses thereof | Physics | 0 | Active |
| US12325745B2 | Anti-DLL3 antibodies and uses thereof | Physics | 0 | Active |
| US11306151B2 | Anti-TIP-1 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11299550B2 | Anti-CD73 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11365242B2 | Anti-apelin antibodies and uses thereof | Human Necessities | 0 | Active |
| US11401329B2 | Anti-CD47 antibodies and uses thereof | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.